Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats

Chemico-Biological Interactions

Volumn 164, Issue 1-2, 2006, Pages 1-14

  Samy, Ramar Perumal ^a   Gopalakrishnakone, Ponnampalam ^a   Ignacimuthu, Savarimuthu ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b LOYOLA COLLEGE   (India)

Author keywords

7,12 Dimethylbenz(a)anthracene; Breast carcinogenesis; Catalase; GPx (glutathione peroxidase); LPx (lipid peroxide); Luteolin; SOD (superoxide dismutase)

Indexed keywords

CATALASE; CYCLOPHOSPHAMIDE; DIMETHYLBENZ[A]ANTHRACENE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; LUTEOLIN; OXYGEN RADICAL; PROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; BREAST; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; HISTOPATHOLOGY; KIDNEY; LIVER; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; TWO DIMENSIONAL GEL ELECTROPHORESIS; WEIGHT REDUCTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BODY WEIGHT; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDES; LUTEOLIN; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33750715421     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.08.018     Document Type: Article

References (36)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., and Thun M.J. Cancer statistics, 2005. CA Cancer J. Clin. 55 1 (2005) 10-30 (Erratum in: CA Cancer J. Clin. 55 (4) (2005) 259. PMID 15661684)
2. Surveillance and Epidemiology and End Results (SEER) program (http://www.seer.cancer.gov) SEER Stat Database: Mortality-All COD, Public-use With State, Total US (1969-2002) National Cancer Institute. DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005. Underlying mortality data provided by NCHS (http://www.cdc.gov.nchs/).
3. Aruoma O.I. Nutrition and health aspects of free radicals and antioxidants. Food Chem. Toxicol. 32 (1994) 671-685
4. Cerutti P.A. Prooxidant states and tumor promotion. Science 227 (1985) 375-381
5. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic. Biol. Med. 8 (1990) 583-599
6. Wilkinson J.I.V., and Clapper M. Detoxification enzymes and chemoprevention. Proc. Soc. Exp. Biol. Med. 216 (1997) 192-200
7. Wattenberg L.W. An overview of chemoprevention: current status and future prospects. Proc. Soc. Exp. Biol. Med. 216 (1997) 133-141
8. Sen C.K. Oxygen toxicity and antioxidants: state of the art. Int. J. Physiol. Pharmacol. 39 (1995) 177-186
9. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. 2nd ed. (1989), Clarendon Press, Oxford pp. 126-131, 152-157, 253-259
10. Gutteridge J.M. Antioxidants, nutritional supplement and life threatening diseases. Br. J. Biomed. Sci. 51 (1994) 288-295
11. Ioset J.R., Marston A., Gupta M.P., and Hostettmann K. A methyflavan with free radical scavenging properties from Pancratium littorale. Fitoterapia 72 (2000) 35-39
12. Wiart C., Kumar A., Norhanom M.R., and Kasturi S. Screening of tropical rain forest plants of Malaysia (Perak) for in vitro anticancer activities. J. Trop. Med. Plants 1 (2000) 6-9
13. Pettit G.R., Hoard M.S., Doubek D.L., Schmidt J.M., Pettit R.K., Tackett L.P., and Chapuis J.C. Actinoplastic agents 338. The cancer cell growth inhibitory constituents of Terminalia arjuna (Combretaceae). J. Ethnopharmacol. 53 (1996) 57-63
14. Wing-Cheung Leung H., Kuo C.L., Yang W.H., Lin C.H., and Lee H.Z. Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. Eur. J. Pharmacol. 508 (2006) 77-83
15. Nair S., Nagar R., and Gupta R. Antioxidant phenolics and flavonoids in common Indian foods. J. Assoc. Physicians of India 46 (1998) 708-710
16. Bors W., Michel C., and Saran M. Flavonoid antioxidants: rate constants for reactions with oxygen radicals. Meth. Enzymol. 234 (1994) 420-429
17. Shimoi K., Masuda S., Furugori M., Esaki S., and Kinae N. Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice. Carcinogenesis 15 (1994) 2669-2672
18. Yasukawa K., Takido M., Takeuchi M., and Nakagawa S. Effect of chemical constituents from plants on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Chem. Pharmaceut. Bull. 37 (1989) 1071-1073
19. Yamamoto H., Sakakibara J., Nagatsu A., and Sekiya K. Inhibitors of arachidonate lipoxygenase from defatted perilla seed. J. Agric. Food Chem. 46 (1998) 862-865
20. Ferriola P.C., Cody V., and Middleton Jr. E. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol. 38 (1989) 1617-1624
21. Sadzuka Y., Sugiyama T., Shimoi K., Kinae N., and Hirota S. Protective effect of flavonoids on doxorubicin-induced cardiotoxicity. Toxicol. Lett. 92 (1997) 1-7
22. Shimoi K., Okada H., Furugori M., Goda T., Takase S., Suzuki M., Hara Y., Yamamoto H., and Kinae N. Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett. 438 (1998) 220-224
23. Kim J.S., Lee H.J., Lee M.H., Kim J., Jin C., and Rvu J.H. Luteolin inhibits LPS-stimulated inducible nitric oxide synthase expression in BV-2 microglial cells. Planta Medica 72 1 (2006) 65-68
24. Huggins C., Grand L.C., and Brillantes F.P. Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Nature 198 (1961) 204-207
25. Costa I., Solanas M., and Escrich E. Histopathologic characterization of mammary neoplastic lesions induced with 7,12-dimethylbenz(a)anthracene in the rat. A comparative analysis with human breast tumor. Arch. Pathol. Lab. Med. 126 (2002) 915-927
26. Ceriani R.L., Blank E.W., and Peterson J.A. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat soluble components. Cancer Res. 47 (1987) 532-540
27. Flohe L., and Otting F. Superoxide dismutase assays. Meth. Enzymol. 105 (1984) 93
28. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid. Anal. Biochem. 95 (1979) 351-358
29. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959) 70-77
30. Claiborne A. Catalase activity. In: Greenwald R.A. (Ed). CRC Handbook of Methods for Oxygen Radical Research (1985), CRC Press, Boca Raton, Florida 283-284
31. Broadford M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72 (1976) 248-254
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
33. Folkman J., and D'Amore P.A. Blood vessel formation: what is the molecular basis?. Cell 87 (1996) 1153-1155
34. Folkman J., Watson K., Ingber D., and Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339 (1989) 58-61
35. Um S.H., Mulhall C., Alisa A., Robyn Ives A., Karani J., Williams R., Bertoletti A., and Behboudi S. α-Fetoprotein impairs APC function and induces their apoptosis. J. Immunol. 173 (2004) 1772-1778
36. Stetler D.A., Rose K.M., and Jacob S.T. Anti-poly(A) polymerase antibodies in sera of tumor-bearing rats and human cancer patients. Proc. Natl. Acad. Sci. 78 (1981) 7732-7773